Edema Factor Adenylate Cyclase Variants Having Potencies That Are Highly Dependent On the N-end Rule


B. anthracis strains BH480; plasmids encoding anthrax edema factor (EF) variants pSJ136EFOS, pSJ 136EFA and pSJ 136EFR.

Potential Commercial Applications: Competitive Advantages:
  • A research material that can be used in the development of assays, validation of products or in quality control.
 
  • Speed up product development with NIH developed material that has already been tested and validated.


Inventors:

Stephen Leppla (NIAID)  ➽ more inventions...

Clinton Leysath (NIAID)  ➽ more inventions...


Intellectual Property:
Research Material – Patent protection is not being pursued for this technology. (IC Reference No. 2013-039)

Publications:
Leysath CR, et al. PMID 24015319

Licensing Contact:
Wade Green,
Email: wade.green@nih.gov
Phone: 301-761-7505

OTT Reference No: E-737-2013-0
Updated: Jun 7, 2018